{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:31:06Z","timestamp":1785429066970,"version":"3.56.0"},"reference-count":73,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Scientific research at Imam Mohammad Ibn Saud Islamic University","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}]},{"award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}],"id":[{"id":"https:\/\/ror.org\/05gxjyb39","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Gliomas are the most frequently encountered tumors in the central nervous system, with limited therapeutic effectiveness owing to their highly invasive nature, intratumoral heterogeneity, and presence of the blood\u2013brain barrier (BBB). Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) is a large, multifunctional transmembrane endocytic receptor that regulates lipid metabolism, cell signaling, and endocytosis in various body tissues, including the brain. LRP1 mediates tumor cell proliferation, invasion, and angiogenesis in gliomas through various cellular signaling mechanisms, including the SP1\/PI3K\/AKT pathway and MAPK\/ERK. The occurrence of LRP1 in the BBB and the recent identification of its increased expression in gliomas have suggested it as a promising therapeutic target for receptor-mediated nanoparticle delivery and treatment of gliomas. LRP1-mediated transcytosis is now being used to enhance the BBB penetration of chemotherapy drugs and radiosensitizers in gliomas, which has resulted in increased overall survival of patients secondary to increased antitumor effectiveness of therapies. Despite the effective preclinical role of LRP1-targeted therapy in glioma models, clinical translation is challenging due to significant heterogeneity in the expression patterns of LRP1 across various subtypes of gliomas, which may affect the clinical responsiveness of drug therapy. Furthermore, concerns related to the pharmacokinetics of therapy and receptor saturation kinetics have rendered its clinical applicability challenging.<\/jats:p>","DOI":"10.3390\/cells15131163","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:52:11Z","timestamp":1782453131000},"page":"1163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of LRP1 in Glioma Progression and Therapeutic Targeting: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0733-3417","authenticated-orcid":false,"given":"Muhanad","family":"Alhujaily","sequence":"first","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: A \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sipos, D., Raposa, B.L., Freihat, O., Simon, M., Mekis, N., Cornacchione, P., and Kov\u00e1cs, \u00c1. (2025). Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes. Cancers, 17.","DOI":"10.3390\/cancers17010146"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma Multiforme (GBM): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/1878-0261.13730","article-title":"The multifaceted therapeutical role of low-density lipoprotein receptor family in high-grade glioma","volume":"18","author":"Mastrantuono","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1152\/physrev.00033.2007","article-title":"The low density lipoprotein receptor-related protein 1: Unique tissue-specific functions revealed by selective gene knockout studies","volume":"88","author":"Lillis","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Shruthi, N.R., Behera, M.M., Naik, S.K., Das, S.K., Gopan, S., Ghosh, A., Sahu, R.N., Patra, S., and Purkait, S. (2022). Elevated expression of cholesterol transporter LRP-1 is crucially implicated in the pathobiology of glioblastoma. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.1003730"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Langlois, B., Perrot, G., Schneider, C., Henriet, P., Emonard, H., Martiny, L., and Dedieu, S. (2010). LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011584"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40880-015-0064-0","article-title":"Roles of low-density lipoprotein receptor-related protein 1 in tumors","volume":"35","author":"Xing","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","article-title":"Low-density lipoprotein receptor-related protein 1: A physiological A\u03b2 homeostatic mechanism with multiple therapeutic opportunities","volume":"136","author":"Sagare","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Van Gool, B., Dedieu, S., Emonard, H., and Roebroek, A.J.M. (2015). The Matricellular Receptor LRP1 Forms an Interface for Signaling and Endocytosis in Modulation of the Extracellular Tumor Environment. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00271"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.matbio.2025.05.004","article-title":"Differential modulation of endothelial cell functionality by LRP1 expression in fibroblasts and cancer-associated fibroblasts via paracrine signals and matrix remodeling","volume":"139","author":"Martin","year":"2025","journal-title":"Matrix Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.20883\/medical.e1221","article-title":"Therapeutic Targeting of Low-density lipoprotein receptor-related protein-1 (LRP1) gene in Ovarian Cancer: A Comprehensive Review","volume":"94","author":"Krishna","year":"2025","journal-title":"J. Med. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/j.1460-2075.1988.tb03306.x","article-title":"Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor","volume":"7","author":"Herz","year":"1988","journal-title":"EMBO J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0896-6273(01)00234-3","article-title":"The LDL receptor gene family: (Un)expected signal transducers in the brain","volume":"29","author":"Herz","year":"2001","journal-title":"Neuron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid \u03b2-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/ATVBAHA.113.301924","article-title":"Low-Density Lipoprotein Receptor\u2013Related Protein-1","volume":"34","author":"Strickland","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1074\/jbc.M201979200","article-title":"Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain","volume":"277","author":"May","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1096\/fj.10-169508","article-title":"Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function","volume":"25","author":"Selvais","year":"2011","journal-title":"FASEB J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jsps.2013.12.015","article-title":"Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs","volume":"22","author":"Harisa","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/nbm.1427","article-title":"In vitro, high-resolution 1H and 31P NMR based analysis of the lipid components in the tissue, serum, and CSF of the patients with primary brain tumors: One possible diagnostic view","volume":"23","author":"Srivastava","year":"2010","journal-title":"NMR Biomed."},{"key":"ref_21","first-page":"2300","article-title":"Human glioblastoma cell lines: Levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein","volume":"60","author":"Blakely","year":"2000","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kuang, S., Huang, L., Huang, B., Song, Y., Shi, J., Yan, Y., and Wu, X. (2025). Targeting LRP1 to Impede Malignant Progression in Glioblastoma: Involving the SP1-Mediated PI3K\/AKT Pathway. Preprint.","DOI":"10.21203\/rs.3.rs-8197635\/v1"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"23647","DOI":"10.18632\/oncotarget.4640","article-title":"Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells","volume":"6","author":"Roy","year":"2015","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.devcel.2021.09.015","article-title":"Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation","volume":"56","author":"Bian","year":"2021","journal-title":"Dev. Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/0008-5472.CAN-08-3379","article-title":"Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The Microenvironmental Landscape of Brain Tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells\u2014A clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: The cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2022.04.010","article-title":"Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma","volume":"8","author":"Pang","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41419-025-07771-1","article-title":"EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis","volume":"16","author":"Yuan","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhou, L., Takayama, Y., Boucher, P., Tallquist, M.D., and Herz, J. (2009). LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006922"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1158\/0008-5472.CAN-07-0683","article-title":"The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development","volume":"67","author":"Montel","year":"2007","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood-2009-04-216473","article-title":"Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes","volume":"114","author":"Lambert","year":"2009","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1182\/blood-2004-07-2617","article-title":"Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1242\/dev.109124","article-title":"The lipoprotein receptor LRP1 modulates sphingosine-1-phosphate signaling and is essential for vascular development","volume":"141","author":"Nakajima","year":"2014","journal-title":"Development"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41467-017-01686-y","article-title":"The role of CXCR3\/LRP1 cross-talk in the invasion of primary brain tumors","volume":"8","author":"Pujol","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/s41388-020-01439-0","article-title":"Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/gcc.20752","article-title":"Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer","volume":"49","author":"Lu","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.32604\/or.2022.025696","article-title":"Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics","volume":"29","author":"Wang","year":"2022","journal-title":"Oncol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Haqqani, A.S., B\u00e9langer, K., and Stanimirovic, D.B. (2024). Receptor-mediated transcytosis for brain delivery of therapeutics: Receptor classes and criteria. Front. Drug Deliv., 4.","DOI":"10.3389\/fddev.2024.1360302"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"74451","DOI":"10.18632\/oncotarget.20165","article-title":"Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ramalho, M.J., Loureiro, J.A., Coelho, M.A., and Pereira, M.C. (2022). Transferrin receptor-targeted nanocarriers: Overcoming barriers to treat glioblastoma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020279"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Shen, X., Li, H., Zhang, B., Li, Y., and Zhu, Z. (2025). Targeting Transferrin Receptor 1 for Enhancing Drug Delivery Through the Blood-Brain Barrier for Alzheimer\u2019s Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199793"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wang, S., Meng, Y., Li, C., Qian, M., and Huang, R. (2015). Receptor-Mediated Drug Delivery Systems Targeting to Glioma. Nanomaterials, 6.","DOI":"10.3390\/nano6010003"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.apha.2014.06.001","article-title":"Transcytosis of macromolecules at the blood-brain barrier","volume":"71","author":"Preston","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Li, C., Zhou, L., and Yin, X. (2024). Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1342181"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00602-1","article-title":"Applications of liposomes and lipid nanoparticles in cancer therapy: Current advances and prospects","volume":"14","author":"Cheng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","article-title":"Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier","volume":"6","author":"Georgieva","year":"2014","journal-title":"Pharmaceutics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/neuonc\/nov096","article-title":"Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation","volume":"18","author":"Gong","year":"2016","journal-title":"Neuro-Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1021\/acs.biomac.1c01103","article-title":"Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma","volume":"22","author":"Wei","year":"2021","journal-title":"Biomacromolecules"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/ntno.38954","article-title":"Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas","volume":"3","author":"Liu","year":"2019","journal-title":"Nanotheranostics"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Duan, M., Cao, R., Yang, Y., Chen, X., Liu, L., Ren, B., Wang, L., and Goh, B.-C. (2024). Blood\u2013Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges. Cancers, 16.","DOI":"10.20944\/preprints202409.0186.v1"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e2303073","DOI":"10.1002\/smll.202303073","article-title":"Drug Repurposing-Based Brain-Targeting Self-Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma","volume":"19","author":"Liang","year":"2023","journal-title":"Small"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1039\/D2NR03683E","article-title":"Angiopep-2-decorated titanium-alloy core-shell magnetic nanoparticles for nanotheranostics and medical imaging","volume":"14","author":"Thirumurugan","year":"2022","journal-title":"Nanoscale"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-020-00751-x","article-title":"LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo","volume":"19","author":"He","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BJ20090175","article-title":"Receptor-associated protein (RAP) has two high-affinity binding sites for the low-density lipoprotein receptor-related protein (LRP): Consequences for the chaperone functions of RAP","volume":"421","author":"Jensen","year":"2009","journal-title":"Biochem. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12974-016-0772-7","article-title":"LRP1 modulates the microglial immune response via regulation of JNK and NF-\u03baB signaling pathways","volume":"13","author":"Yang","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sivasoorian, S.S., Urade, R., Chiu, C.C., and Wang, L.F. (2022). Neuropeptide-Functionalized Gold Nanorod Enhanced Cellular Uptake and Improved In Vitro Photothermal Killing in LRP1-Positive Glioma Cells. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091939"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbrc.2020.10.076","article-title":"Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB","volume":"534","author":"Zhu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1800316","DOI":"10.1002\/adma.201800316","article-title":"Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo","volume":"30","author":"Jiang","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"495103","DOI":"10.1088\/0957-4484\/26\/49\/495103","article-title":"Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: Two new strategies of functionalization with apolipoprotein E","volume":"26","author":"Neves","year":"2015","journal-title":"Nanotechnology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1080\/09205063.2017.1348739","article-title":"Glioma targeted delivery strategy of doxorubicin-loaded liposomes by du-al-ligand modification","volume":"28","author":"Han","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1080\/10717544.2022.2108937","article-title":"A tumor microenvironment-responsive micelle co-delivered radiosensitizer Dbait and doxorubicin for the collaborative chemo-radiotherapy of glioblastoma","volume":"29","author":"Zhang","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/10717544.2018.1534897","article-title":"Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy","volume":"26","author":"Zong","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S123422","article-title":"Angiopep-2-conjugated poly(ethylene glycol)-co-poly(\u03b5-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats","volume":"12","author":"Lu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2105451","DOI":"10.1002\/advs.202105451","article-title":"Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1021\/acs.bioconjchem.5c00352","article-title":"A Next-Generation Brain-Targeting Peptide: KS-487 Rivals Angiopep-2 in BBB Penetration with Enhanced Selectivity","volume":"36","author":"Asukabe","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"ref_70","first-page":"101367","article-title":"Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability and BBB permeability","volume":"32","author":"Sakamoto","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_71","first-page":"vdae186","article-title":"Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma","volume":"6","author":"Dmello","year":"2024","journal-title":"Neurooncol. Adv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1078-0432.CCR-12-2481","article-title":"Phase I study of GRN1005 in recurrent malignant glioma","volume":"19","author":"Drappatz","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1007\/s13346-024-01659-x","article-title":"Chemical engineering of zein with polyethylene glycol and Angiopep-2 to manufacture a brain-targeted docetaxel nanomedicine for glioblastoma treatment","volume":"14","author":"Awad","year":"2024","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:20:37Z","timestamp":1782454837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":73,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cells15131163"],"URL":"https:\/\/doi.org\/10.3390\/cells15131163","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}